Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells.

Whitbread AK, Veveris-Lowe TL, Dong Y, Tan OL, Gardiner R, Samaratunga HM, Nicol DL, Clements JA.

Biol Chem. 2010 Apr;391(4):461-6. doi: 10.1515/BC.2010.043.

PMID:
20180647
2.

Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.

Lawrence MG, Veveris-Lowe TL, Whitbread AK, Nicol DL, Clements JA.

Cells Tissues Organs. 2007;185(1-3):111-5. Review.

PMID:
17587816
3.

Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.

Veveris-Lowe TL, Kruger SJ, Walsh T, Gardiner RA, Clements JA.

Semin Thromb Hemost. 2007 Feb;33(1):87-99. Review.

PMID:
17253195
4.

The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.

Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA.

Biol Chem. 2006 Jun;387(6):707-14. Review.

PMID:
16800731
5.

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.

Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.

Endocr Relat Cancer. 2005 Sep;12(3):631-43.

PMID:
16172196
6.

Co-expression of GH and GHR isoforms in prostate cancer cell lines.

Chopin LK, Veveris-Lowe TL, Philipps AF, Herington AC.

Growth Horm IGF Res. 2002 Apr;12(2):126-36.

PMID:
12175650

Supplemental Content

Loading ...
Support Center